Search

Your search keyword '"Field, Thalia S."' showing total 712 results

Search Constraints

Start Over You searched for: Author "Field, Thalia S." Remove constraint Author: "Field, Thalia S."
712 results on '"Field, Thalia S."'

Search Results

3. Specialist Perspectives on the Imaging Selection of Large Vessel Occlusion in the Late Window

4. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study

7. Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase

8. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

9. External validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis

14. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

15. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial

17. Neuroimaging standards for research into small vessel disease—advances since 2013

18. Management of blunt cerebrovascular injuries at a Canadian level 1 trauma centre: Are we meeting the grade?

20. Reducing the global burden of cerebral venous thrombosis: An international research agenda

21. An interrupted time-series analysis of the impact of COVID-19 on hospitalizations for vascular events in three Canadian provinces

24. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

26. Infarcts in a New Territory: Insights From the ESCAPE-NA1 Trial

29. Effect of incomplete reperfusion patterns on clinical outcome: insights from the ESCAPE-NA1 trial.

30. A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial.

31. Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke.

33. Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial

34. Contributors

37. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

39. Abstract TMP14: Population-Based Intracranial Vascular Imaging for Acute Ischemic Stroke is Suboptimal

40. Abstract TMP108: External Validation of the SI 2 NCAL 2 C Score for Mortality Following Cerebral Venous Thrombosis

42. Abstract WMP11: Intravenous Thrombolysis in Patients Without versus With Visible Occlusion: A Secondary Analysis From the AcT Trial

43. Infarct Evolution on MR-DWI After Thrombectomy in Acute Stroke Patients Randomized to Nerinetide or Placebo

45. Prevalence of Walking Limitation After Acute Stroke and Its Impact on Discharge to Home

46. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase

47. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis

48. Anticoagulation Versus Antiplatelets in Spontaneous Cervical Artery Dissection: A Systematic Review and Meta-Analysis

50. Reshaping the path of vascular cognitive impairment with progressive resistance training: A 12‐Month Randomized Trial

Catalog

Books, media, physical & digital resources